Clinical Trials And Registries To Prevent Blindness For Macular Disease
Funder
National Health and Medical Research Council
Funding Amount
$467,961.00
Summary
Injection of drugs into the eye is an unprecedented breakthrough in the treatment of macular diseases, however many questions must be addressed for our patients with diabetic retinopathy and macular degeneration to reap the full benefits. My clinical research unit will conduct our own clinical trials, such as testing a new laser that has never been used in the retina. My observational studies unit will track “real world” outcomes of treatment of retinal disease in a large group of Australians.
Molecular Profiling To Identify Therapeutic Targets For Blinding Diseases.
Funder
National Health and Medical Research Council
Funding Amount
$467,961.00
Summary
Understanding the molecular mechanisms underlying blinding diseases will allow for the development of new therapies. As an ophthalmologist with sub-specialty training in genetic eye diseases, this fellowship will enhance the synergy between my current research and clinical practice. During this fellowship I will lead research to uncover further genetic associations for eye disease, as well as interrogate patient-specific cell lines to elucidate specific signatures of disease development.